0 Évaluations
ID

12119

Description

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT; ODM derived from: https://clinicaltrials.gov/show/NCT02460887

Lien

https://clinicaltrials.gov/show/NCT02460887

Mots-clés

Versions (1)
  1. 24/09/2015 24/09/2015 - Julian Varghese
Téléchargé le

24 septembre 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Nasopharyngeal Carcinoma NCT02460887

    Anglais

    Eligibility Nasopharyngeal Carcinoma NCT02460887

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patients with newly histologically confirmed non-keratinizing nasopharyngeal carcinoma (including who ii or iii).
    Description

    Nasopharyngeal Nonkeratinizing Carcinoma

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1334926
    tumor staged as t1-4n2-3或t3-4n0-1m0 (according to the 7th ajcc edition).
    Description

    AJCC tumor staging

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0441915
    satisfactory performance status: karnofsky scale (kps) ≥ 70.
    Description

    satisfactory performance status: karnofsky scale

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    adequate marrow: leucocyte count ≥ 4000/μl, hemoglobin ≥ 90g/l and platelet count ≥
    Description

    platelet count; hemoglobin

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023508
    UMLS CUI [2]
    C0005821
    UMLS CUI [3]
    C0019046
    adequate liver function: alanine aminotransferase (alt), aspartate aminotransferase (ast) < 1.5×upper limit of normal (uln) concomitant with alkaline phosphatase (alp) ≤ 2.5×uln
    Description

    alkaline phosphatase; concomitant; normal; liver; upper; ast; uln

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0376147
    UMLS CUI [2]
    C0242192
    UMLS CUI [3]
    C0201850
    and bilirubin ≤1.5×uln.
    Description

    bilirubin; uln

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1278039
    adequate renal function: creatinine clearance ≥ 60 ml/min.
    Description

    creatinine clearance; renal function

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0373595
    patients must be informed of the investigational nature of this study and give written informed consent.
    Description

    written informed consent.; study

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
    Description

    Basaloid squamous cell carcinoma | Squamous cell carcinoma, keratinizing

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1266005
    UMLS CUI [2]
    C0334247
    treatment with palliative intent.
    Description

    palliative; treatment; intent

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111
    UMLS CUI [1,2]
    C1285530
    prior malignancy except adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer.
    Description

    prior malignancy; cervical; squamous; cancer; skin

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    pregnancy or lactation (consider pregnancy test in women of child-bearing age and emphasize effective contraception during the treatment period).
    Description

    Patient currently pregnant | Lactating (finding)

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0549206
    UMLS CUI [2]
    C2828358
    history of previous rt (except for non-melanomatous skin cancers outside intended rt treatment volume).
    Description

    history of previous rt

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1522449
    prior chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
    Description

    prior chemotherapy; primary tumor; surgery; nodes

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    UMLS CUI [2,1]
    C0038894
    UMLS CUI [2,2]
    C0006826
    any severe intercurrent disease, which may bring unacceptable risk or affect the compliance of the trial, for example, unstable cardiac disease requiring treatment, renal disease, chronic hepatitis, diabetes with poor control (fasting plasma glucose > 1.5×uln), and emotional disturbance.
    Description

    Disease condition determination, uncontrolled | Compliance behavior | Heart Diseases; Unstable status | Kidney Diseases | Hepatitis, Chronic | Diabetes mellitus poor control | Emotional Disturbances

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0184774
    UMLS CUI [2]
    C1321605
    UMLS CUI [3,1]
    C0018799
    UMLS CUI [3,2]
    C0443343
    UMLS CUI [4]
    C0022658
    UMLS CUI [5]
    C0019189
    UMLS CUI [6]
    C0860161
    UMLS CUI [7]
    C0013985
    Retour au début de la page

    Similar models

    Eligibility Nasopharyngeal Carcinoma NCT02460887

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Nasopharyngeal Nonkeratinizing Carcinoma
    Item
    patients with newly histologically confirmed non-keratinizing nasopharyngeal carcinoma (including who ii or iii).
    boolean
    C1334926 (UMLS CUI [1])
    AJCC tumor staging
    Item
    tumor staged as t1-4n2-3或t3-4n0-1m0 (according to the 7th ajcc edition).
    boolean
    C0441915 (UMLS CUI [1])
    satisfactory performance status: karnofsky scale
    Item
    satisfactory performance status: karnofsky scale (kps) ≥ 70.
    boolean
    C1520224 (UMLS CUI [1])
    platelet count; hemoglobin
    Item
    adequate marrow: leucocyte count ≥ 4000/μl, hemoglobin ≥ 90g/l and platelet count ≥
    boolean
    C0023508 (UMLS CUI [1])
    C0005821 (UMLS CUI [2])
    C0019046 (UMLS CUI [3])
    alkaline phosphatase; concomitant; normal; liver; upper; ast; uln
    Item
    adequate liver function: alanine aminotransferase (alt), aspartate aminotransferase (ast) < 1.5×upper limit of normal (uln) concomitant with alkaline phosphatase (alp) ≤ 2.5×uln
    boolean
    C0376147 (UMLS CUI [1])
    C0242192 (UMLS CUI [2])
    C0201850 (UMLS CUI [3])
    bilirubin; uln
    Item
    and bilirubin ≤1.5×uln.
    boolean
    C1278039 (UMLS CUI [1])
    creatinine clearance; renal function
    Item
    adequate renal function: creatinine clearance ≥ 60 ml/min.
    boolean
    C0373595 (UMLS CUI [1])
    written informed consent.; study
    Item
    patients must be informed of the investigational nature of this study and give written informed consent.
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Basaloid squamous cell carcinoma | Squamous cell carcinoma, keratinizing
    Item
    who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
    boolean
    C1266005 (UMLS CUI [1])
    C0334247 (UMLS CUI [2])
    palliative; treatment; intent
    Item
    treatment with palliative intent.
    boolean
    C0087111 (UMLS CUI [1,1])
    C1285530 (UMLS CUI [1,2])
    prior malignancy; cervical; squamous; cancer; skin
    Item
    prior malignancy except adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer.
    boolean
    C0006826 (UMLS CUI [1])
    Patient currently pregnant | Lactating (finding)
    Item
    pregnancy or lactation (consider pregnancy test in women of child-bearing age and emphasize effective contraception during the treatment period).
    boolean
    C0549206 (UMLS CUI [1])
    C2828358 (UMLS CUI [2])
    history of previous rt
    Item
    history of previous rt (except for non-melanomatous skin cancers outside intended rt treatment volume).
    boolean
    C1522449 (UMLS CUI [1])
    prior chemotherapy; primary tumor; surgery; nodes
    Item
    prior chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
    boolean
    C0392920 (UMLS CUI [1])
    C0038894 (UMLS CUI [2,1])
    C0006826 (UMLS CUI [2,2])
    Disease condition determination, uncontrolled | Compliance behavior | Heart Diseases; Unstable status | Kidney Diseases | Hepatitis, Chronic | Diabetes mellitus poor control | Emotional Disturbances
    Item
    any severe intercurrent disease, which may bring unacceptable risk or affect the compliance of the trial, for example, unstable cardiac disease requiring treatment, renal disease, chronic hepatitis, diabetes with poor control (fasting plasma glucose > 1.5×uln), and emotional disturbance.
    boolean
    C0184774 (UMLS CUI [1])
    C1321605 (UMLS CUI [2])
    C0018799 (UMLS CUI [3,1])
    C0443343 (UMLS CUI [3,2])
    C0022658 (UMLS CUI [4])
    C0019189 (UMLS CUI [5])
    C0860161 (UMLS CUI [6])
    C0013985 (UMLS CUI [7])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial